--- title: "The three major indices opened higher, with AI and biopharmaceutical stocks continuing their upward trend" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/275545211.md" description: "The three major Hong Kong stock indices opened higher today, with the Hang Seng Index rising 0.23%, the Hang Seng China Enterprises Index up 0.17%, and the Hang Seng TECH Index increasing by 0.21%. Technology stocks rebounded, with AI application concept stocks rising, and Zhizhu opened nearly 5% higher. Biopharmaceutical stocks were active, with Zai Lab and WuXi Biologics both rising over 3%. Gold and non-ferrous metal stocks moved up, with WanGuo Gold Group increasing nearly 8%. Some semiconductor, catering, and oil stocks declined, with SMIC falling over 3%" datetime: "2026-02-11T03:16:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275545211.md) - [en](https://longbridge.com/en/news/275545211.md) - [zh-HK](https://longbridge.com/zh-HK/news/275545211.md) --- > 支持的语言: [English](https://longbridge.com/en/news/275545211.md) | [繁體中文](https://longbridge.com/zh-HK/news/275545211.md) # The three major indices opened higher, with AI and biopharmaceutical stocks continuing their upward trend \[News Report\] The three major indices of the Hong Kong stock market continued to open higher today (11th), with the Hang Seng Index rising by 0.23%, the National Index up by 0.17%, and the Hang Seng TECH Index increasing by 0.21%. Most heavyweight technology stocks continued to rebound, with AI application concept stocks rising further. Leading stock Zhipu (02513) opened nearly 5% higher, expected to reach a new historical high. Fu Bo Group, SenseTime, and others also saw increases, while biopharmaceutical stocks were collectively active, with Zai Lab and WuXi Biologics rising over 3%. Gold and non-ferrous metal stocks collectively moved upward, with WanGuo Gold Group (03939) rising nearly 8%, Zijin Mining International (02259) and Jinli Permanent Magnet (06680) increasing over 4%, Luoyang Molybdenum (03993) and Lingbao Gold (03330) rising over 3%, and Chifeng Jilong Gold (06693) and Zijin Mining (02899) increasing over 2%. Additionally, some semiconductor stocks, catering stocks, and oil stocks declined, with heavyweight stock SMIC (00981) falling over 3% ### 相关股票 - [WUXI BIO (02269.HK)](https://longbridge.com/zh-CN/quote/02269.HK.md) - [WuXi Biologics (WXXWY.US)](https://longbridge.com/zh-CN/quote/WXXWY.US.md) - [ZAI LAB (09688.HK)](https://longbridge.com/zh-CN/quote/09688.HK.md) - [Hang Seng TECH Index (STECH.HK)](https://longbridge.com/zh-CN/quote/STECH.HK.md) - [Zai Lab (ZLAB.US)](https://longbridge.com/zh-CN/quote/ZLAB.US.md) - [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-CN/quote/159837.CN.md) - [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/zh-CN/quote/516820.CN.md) - [Penghua SSE STAR Biology and Medicine ETF (588250.CN)](https://longbridge.com/zh-CN/quote/588250.CN.md) - [Founder Fubon CSI Medicine and Medical Device Innovation ETF (560600.CN)](https://longbridge.com/zh-CN/quote/560600.CN.md) - [ICBCCS SSE STAR Biology and Medicine ETF (588860.CN)](https://longbridge.com/zh-CN/quote/588860.CN.md) - [China Universal 800 Health Care ETF (159929.CN)](https://longbridge.com/zh-CN/quote/159929.CN.md) - [Guotai SSE STAR Brand Name Drug ETF (589720.CN)](https://longbridge.com/zh-CN/quote/589720.CN.md) - [China Southern Hang Seng Biotech ETF(QDII) (159615.CN)](https://longbridge.com/zh-CN/quote/159615.CN.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-CN/quote/IBB.US.md) - [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-CN/quote/159849.CN.md) - [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-CN/quote/512010.CN.md) - [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-CN/quote/XBI.US.md) - [Hwabao WP Hang Seng SCHK Innovative Drug Select ETF (520880.CN)](https://longbridge.com/zh-CN/quote/520880.CN.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-CN/quote/BIB.US.md) - [GF CSI HK Innovative Drugs Industry ETF(QDII) (513120.CN)](https://longbridge.com/zh-CN/quote/513120.CN.md) - [Bosera Hang Seng SCHK Innovative Drug Select ETF (520690.CN)](https://longbridge.com/zh-CN/quote/520690.CN.md) - [Huaan Hang Seng Biotech ETF (159102.CN)](https://longbridge.com/zh-CN/quote/159102.CN.md) - [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-CN/quote/510660.CN.md) - [Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF (159506.CN)](https://longbridge.com/zh-CN/quote/159506.CN.md) ## 相关资讯与研究 - [Biocytogen and Sihuan partner to advance new therapeutics for weight loss](https://longbridge.com/zh-CN/news/281501537.md) - [Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase](https://longbridge.com/zh-CN/news/281231901.md) - [ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma](https://longbridge.com/zh-CN/news/281068292.md) - [10:00 ETSanyou Milestone | Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence](https://longbridge.com/zh-CN/news/281035304.md) - [Assessing BioArctic (OM:BIOA B) Valuation After New Lecanemab Data And Regulatory Milestones](https://longbridge.com/zh-CN/news/281644038.md)